Cosette Pharmaceuticals acquires SYMPAZAN and six other branded drugs
Cosette Pharmaceuticals announced the completion of its acquisition of U.S. sales and distribution rights for seven branded pharmaceutical products from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
